CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,138,950
- in 5 filings, $4.8M under 10b5-1 plans
Net −$7,138,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-31 | Longpre Lara Chief Development Officer | Grant or award · Stock Option (right to buy) | +38,500 | 38,500 | ||
| 2023-01-31 | Vig Pamela Head of Research & Development | Grant or award | +9,625 | 31,527 | ||
| 2023-01-31 | Vig Pamela Head of Research & Development | Grant or award · Stock Option (right to buy) | +38,500 | 38,500 | ||
| 2023-01-31 | Radovich Peter Chief Operating Officer | Grant or award | +14,440 | 38,132 | ||
| 2023-01-31 | Radovich Peter Chief Operating Officer | Grant or award · Stock Option (right to buy) | +57,750 | 57,750 | ||
| 2023-01-09 | Radovich Peter PRESIDENT AND COO | Sale | −1,379 | $20.62 | $28K | 33,316 |
| 2023-01-09 | Vig Pamela CHIEF SCIENTIFIC OFFICER | Sale | −1,379 | $20.62 | $28K | 27,312 |
| 2023-01-09 | Longpre Lara CHIEF DEVELOPMENT OFFICER | Sale | −1,003 | $20.62 | $21K | 104,369 |
| 2023-01-09 | Peetz Christopher CHIEF EXECUTIVE OFFICER | Sale | −5,159 | $20.62 | $106K | 91,953 |
| 2019-09-10 | Longpre Lara CHIEF DEVELOPMENT OFFICER | Purchase | +965 | $10.64 | $10K | 105,372 |
Page 25 of 25 · 490 trades